Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|May 4, 2026
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate CancerCatharina J P Op 't Hoog, Niven Mehra, Benthe van der Weij, et al.
British Journal of Clinical Pharmacology|May 3, 2020
The relationship between sunitinib exposure and both efficacy and toxicity in real-world patients with renal cell carcinoma and gastrointestinal stromal tumourKim Westerdijk, Stefanie D Krens, Winette T A van der Graaf, et al.
The Lancet. Oncology|April 4, 2019
Dose recommendations for anticancer drugs in patients with renal or hepatic impairmentStefanie D Krens, Gerben Lassche, Frank G A Jansman, et al.
Anti-Cancer Drugs|March 17, 2016
A successful approach to overcome imatinib-induced skin toxicity in a GIST patientIngrid M E Desar, Carla M L van Herpen, Nielka P van Erp, et al.
International Journal of Cancer|September 8, 2021
Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancerStefanie D Krens, Wim van Boxtel, Maike J M Uijen, et al.
Clinical Pharmacokinetics|April 24, 2016
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and EnzalutamideGuillemette E Benoist, Rianne J Hendriks, Peter F A Mulders, et al.
Cancer Medicine|October 30, 2023
Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitatorsKim Westerdijk, Neeltje Steeghs, Casper S J Tacke, et al.
Pharmaceutical Research|November 17, 2019
Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic StudyMarie-Rose B S Crombag, Thomas P C Dorlo, Ellen van der Pan, et al.
British Journal of Clinical Pharmacology|November 23, 2025
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancerCatharina J P Op 't Hoog, Niven Mehra, Anouk van Kleef, et al.
Biomedical Chromatography : BMC|April 4, 2017
Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasmaGuillemette E Benoist, Eric van der Meulen, Floor J E Lubberman, et al.
Pageof 11